Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants

被引:36
作者
He, Max M. [1 ,2 ]
Li, Quan [3 ]
Yan, Muqing [1 ]
Cao, Hui [1 ]
Hu, Yue [1 ]
He, Karen Y. [4 ]
Cao, Kajia [5 ]
Li, Marilyn M. [5 ,6 ]
Wang, Kai [3 ,6 ]
机构
[1] Simcere Diagnost Co Ltd, Nanjing 210042, Jiangsu, Peoples R China
[2] State Key Lab Translat Med & Innovat Drug Dev, Nanjing 210042, Jiangsu, Peoples R China
[3] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA
[4] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[5] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Genom Diagnost, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
Somatic variant interpretation; Genetic diagnosis; Cancer genetics; Standards and guidelines; JOINT-CONSENSUS-RECOMMENDATION; AMINO-ACID SUBSTITUTIONS; SEQUENCE VARIANTS; GENETIC-VARIATION; MUTATIONS; ASSOCIATION; GUIDELINES; STANDARDS; DATABASE; COLLEGE;
D O I
10.1186/s13073-019-0664-4
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Clinical laboratories implement a variety of measures to classify somatic sequence variants and identify clinically significant variants to facilitate the implementation of precision medicine. To standardize the interpretation process, the Association for Molecular Pathology (AMP), American Society of Clinical Oncology (ASCO), and College of American Pathologists (CAP) published guidelines for the interpretation and reporting of sequence variants in cancer in 2017. These guidelines classify somatic variants using a four-tiered system with ten criteria. Even with the standardized guidelines, assessing clinical impacts of somatic variants remains to be tedious. Additionally, manual implementation of the guidelines may vary among professionals and may lack reproducibility when the supporting evidence is not documented in a consistent manner. Results We developed a semi-automated tool called "Variant Interpretation for Cancer" (VIC) to accelerate the interpretation process and minimize individual biases. VIC takes pre-annotated files and automatically classifies sequence variants based on several criteria, with the ability for users to integrate additional evidence to optimize the interpretation on clinical impacts. We evaluated VIC using several publicly available databases and compared with several predictive software programs. We found that VIC is time-efficient and conservative in classifying somatic variants under default settings, especially for variants with strong and/or potential clinical significance. Additionally, we also tested VIC on two cancer-panel sequencing datasets to show its effectiveness in facilitating manual interpretation of somatic variants. Conclusions Although VIC cannot replace human reviewers, it will accelerate the interpretation process on somatic variants. VIC can also be customized by clinical laboratories to fit into their analytical pipelines to facilitate the laborious process of somatic variant interpretation. VIC is freely available at https://github.com/HGLab/VIC/.
引用
收藏
页数:14
相关论文
共 32 条
  • [31] Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
    Tamborero, David
    Rubio-Perez, Carlota
    Deu-Pons, Jordi
    Schroeder, Michael P.
    Vivancos, Ana
    Rovira, Ana
    Tusquets, Ignasi
    Albanell, Joan
    Rodon, Jordi
    Tabernero, Josep
    de Torres, Carmen
    Dienstmann, Rodrigo
    Gonzalez-Perez, Abel
    Lopez-Bigas, Nuria
    [J]. GENOME MEDICINE, 2018, 10
  • [32] ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
    Wang, Kai
    Li, Mingyao
    Hakonarson, Hakon
    [J]. NUCLEIC ACIDS RESEARCH, 2010, 38 (16) : e164